Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s)

Biochemical Pharmacology

Volumn 81, Issue 5, 2011, Pages 626-635

  Moroy, Gautier ^a   Bourguet, Erika ^b   Decarme, Martine ^b   Sapi, Janos ^b   Alix, Alain J P ^b   Hornebeck, William ^b   Lorimier, Sandrine ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Leukocyte elastase; Matrix metalloproteinase; Molecular docking; Oleic acid; Oleoyl galardin; Plasmin

Indexed keywords

CARBOXYLIC ACID; COLLAGEN; COLLAGENASE 3; FATTY ACID; GELATINASE A; GELATINASE B; HYDROXAMIC ACID; ILOMASTAT; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE INHIBITOR; OLEIC ACID; PHENYLALANINE; PLASMIN; TYROSINE; VALINE; ZINC;

AMINO TERMINAL SEQUENCE; ARTICLE; CHELATION; CONTROLLED STUDY; COVALENT BOND; DRUG POTENCY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROPHOBICITY; LEUKOCYTE; MOLECULAR DOCKING; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION;

DIPEPTIDES; ENZYME ACTIVATION; FIBRINOLYSIN; HUMANS; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASES; MODELS, MOLECULAR; OLEIC ACID; OLEIC ACIDS; PROTEIN BINDING; PROTEIN PRECURSORS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79551471783     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.12.001     Document Type: Article

References (54)

1. S.A. Eming, T. Krieg, and J.M. Davidson Inflammation in wound repair: molecular and cellular mechanisms J Invest Dermatol 127 2007 514 525
2. M. Toriseva, and V.M. Kähri Proteinases in cutaneous wound healing Cell Mol Life Sci 66 2009 203 224
3. N.J. Trengove, M.C. Stacey, S. MacAuley, N. Bennett, A.J. Gibson, and F. Burslem Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors Wound Rep Reg 7 6 1999 442 452
4. S.E. Gill, and W.C. Parks Metalloproteinases and their inhibitors: regulators of wound healing Int J Biochem Cell Biol 40 2008 1334 1347
5. B. Barrick, E.J. Campbell, and C.A. Owen Leukocyte proteinases in wound healing: roles in physiologic and pathologic processes Wound Rep Reg 7 1999 410 422
6. U.K. Saarialho-Kere Patterns of MMPs and TIMP expression in chronic wounds Arch Dermatol Res 290 Suppl. 1998 547 554
7. H. Nagase, R. Visse, and G. Murphy Structure and function of matrix metalloproteinases and TIMPs Cardiovasc Res 69 2006 562 573
8. A. Page-McCaw, A.J. Ewald, and Z. Werb Matrix metalloproteinases and the regulation of tissue remodelling Nat Rev Mol Cell Biol 8 2007 221 233
9. S.D. Shapiro, N.M. Goldstein, A.M. Houghton, D.K. Kobayashi, D. Kelley, and A. Belaaouaj Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice Am J Pathol 163 6 2003 2329 2335
10. Y.S. Park, H.J. Jang, K.H. Lee, T.R. Hahn, and Y.S. Paik Prolyl endopeptidase inhibitory activity of unsaturated fatty acids J Agric Food Chem 54 4 2006 1238 1242
11. H. Kido, N. Fukusen, and N. Katunama Inhibition of chymase activity by long chain fatty acids Arch Biochem Biophys 230 2 1984 610 614
12. F.G. Hamel Preliminary report: inhibition of cellular proteasome activity by free fatty acids Metabolism 58 8 2009 1047 1049
13. D. Wang, T.J. Girard, T.P. Kasten, R.M. LaChance, M.A. Miller-Wideman, and R.C. Durley Inhibitory activity of unsaturated fatty acids and anacardic acids toward soluble tissue factor-factor VIIa complex J Nat Prod 61 11 1998 1352 1355
14. W. Hornebeck, E. Moczar, J. Szecsi, and L. Robert Fatty acid peptide derivatives as model compounds to protect elastin against degradation by elastases Biochem Pharmacol 34 18 1985 3315 3321
15. S.C. Tyagi, and S.R. Simon Inhibitors directed to binding domains in neutrophil elastase Biochemistry 29 1990 9970 9977
16. A. Shock, H. Baum, M.F. Kapasi, F.M. Bull, and P.J. Quinn The susceptibility of elastin-fatty acid complexes to elastolytic enzymes Matrix 10 3 1990 179 185
17. A. Berton, V. Rigot, E. Huet, M. Decarme, Y. Eeckhout, and L. Patthy Involvement of fibronectin type II repeats in the efficient inhibition of gelatinases A and B by long-chain unsaturated fatty acids J Biol Chem 276 23 2001 20458 20465
18. E. Huet, J.H. Cauchard, A. Berton, A. Robinet, M. Decarme, and W. Hornebeck Inhibition of plasmin-mediated prostromelysin-1 activation by interaction of long chain unsaturated fatty acids with kringle 5 Biochem Pharmacol 67 4 2004 643 654 Erratum in: ibid 2004;67(5):1011
19. C. Kerneur, W. Hornebeck, L. Robert, and E. Moczar Inhibition of human leucocyte elastase by fatty acyl-benzisothiazolinone, 1,1-dioxide conjugates (fatty acyl-saccharins) Biochem Pharmacol 45 9 1993 1889 1895
20. A. Baici, C. Diczhazi, A. Neszmelyi, E. Moczar, and W. Hornebeck Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin Biochem Pharmacol 46 9 1993 1545 1549
21. M. Kunishima, C. Kawachi, J. Morita, K. Terao, F. Iwasaki, and S. Tani 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride: an efficient condensing agent leading to the formation of amides and esters Tetrahedron 55 1999 13159 13170
22. N. Lewis, A. McKillop, R. Taylor, and R. Watson A simple and efficient procedure for the preparation of chiral 2-oxazolidinones from α-amino acids Synth Commun 25 1995 561 568
23. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, and R.K. Belew Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function J Comput Chem 19 1998 1639 1662
24. R. Huey, G.M. Morris, A.J. Olson, and D.S. Goodsell A semiempirical free energy force field with charge-based desolvation J Comput Chem 28 6 2007 1145 1152
25. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, and J.R. Cheeseman Gaussian 03, Revision B.05 2004 Gaussian, Inc. Wallingford, CT
26. W. Bode, A.Z. Wei, R. Huber, E. Meyer, J. Travis, and S. Neumann X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor EMBO J 5 10 1986 2453 2458
27. E. Morgunova, A. Tuuttila, U. Bergmann, M. Isupov, Y. Lindqvist, and G. Schneider Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed Science 284 5420 1999 1667 1670
28. M.D. Battistel, A. Grishaev, S.S. An, F.J. Castellino, and M. Llinás Solution structure and functional characterization of human plasminogen kringle 5 Biochemistry 48 43 2009 10208 10219
29. J.A. Blagg, M.C. Noe, L.A. Wolf-Gouveia, L.A. Reiter, E.R. Laird, and S.P. Chang Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14 Bioorg Med Chem Lett 15 7 2005 1807 1810
30. H. Li, A.D. Robertson, and J.H. Jensen Very fast empirical prediction and rationalization of protein pKa values Proteins 61 4 2005 704 721
31. D.C. Bas, D.M. Rogers, and J.H. Jensen Very fast prediction and rationalization of pKa values for protein-ligand complexes Proteins 73 3 2008 765 783
32. L. Cook, and B. Ternai Similar binding sites for unsaturated fatty acids and alkyl 2-pyrone inhibitors of human sputum elastase Biol Chem Hoppe Seyler 369 7 1988 627 631
33. 1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies Bioorg Med Chem 15 14 2007 4753 4766
34. G. Ledour, G. Moroy, M. Rouffet, E. Bourguet, D. Guillaume, and M. Decarme Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity Bioorg Med Chem 16 18 2008 8745 8759
35. H. Emonard, V. Marcq, C. Mirand, and W. Hornebeck Inhibition of gelatinase A by oleic acid Ann N Y Acad Sci 878 1999 647 649
36. D.E. Levy, F. Lapierre, W. Liang, W. Ye, C.W. Lange, and X. Li Matrix metalloproteinase inhibitors: a structure-activity study J Med Chem 41 1998 199 223
37. H. Nagase Activation mechanisms of matrix metalloproteinases Biol Chem 378 1997 151 160
38. H. Nagase, J.J. Enghild, K. Susuki, and G. Salvesen Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate Biochemistry 29 324 1990 5783 5789
39. J.L. Lauer-Fields, J.K. Whitehead, S. Li, R.P. Hammer, K. Brew, and G.B. Fields Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition J Biol Chem 283 29 2008 20087 20095
40. X. Xu, Z. Chen, Y. Wang, L. Bonewald, and B. Steffensen Inhibition of MMP-2 gelatinolysis by targeting exodomain-substrate interactions Biochem J 406 2007 147 155
41. P.S. Frank, J.T. Douglas, M. Locher, M. Llinas, and J. Schaller Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide Biochemistry 42 4 2003 1078 1085
42. M. Trexler, K. Briknarova, M. Gehrmann, M. Llinas, and L. Patthy Peptide ligands for the fibronectin type II modules of matrix metalloproteinase 2 (MMP-2) J Biol Chem 278 14 2003 12241 12246
43. X. Xu, M. Mikhailova, U. Ilangovan, Z. Chen, A. Yu, and S. Pal Nuclear magnetic resonance mapping and functional confirmation of the collagen binding sites of matrix metalloproteinase-2 Biochemistry 48 2009 5822 5831
44. A. Berton, G. Godeau, H. Emonard, K. Baba, P. Bellon, and W. Hornebeck Analysis of the ex vivo specificity of human gelatinases A and B towards skin collagen and elastic fibers by computerized morphometry Matrix Biol 19 2 2000 139 148
45. D. Grobelny, L. Poncz, and R.E. Galardy Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids Biochemistry 31 31 1992 7152 7154
46. L. Stanislawski, and W. Hornebeck Effect of sodium oleate on the hydrolysis of human plasma fibronectin by proteinases Biochem Int 16 4 1988 661 670
47. A. Heim-Riether, S.J. Taylor, S. Liang, D.A. Gao, Z. Xiong, and E.M. August Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors Bioorg Med Chem Lett 19 2009 5321 5324
48. L.T. Gooljarsingh, A. Lakdawala, F. Coppo, L. Luo, G.B. Fields, and P.J. Tummino Characterization of an exosite binding inhibitor of matrix metalloproteinases 13 Prot Sci 17 2008 66 71
49. M. Jani, H. Tordai, M. Trexler, L. Banyai, and L. Patthy Hydroxamate-based peptide inhibitors of matrix metalloprotease 2 Biochimie 87 2005 385 392
50. S. Momohara, S. Kashiwasaki, K. Inoue, S. Saito, and T. Nakagawa Elastase from polymorphonuclear leukocyte in articular cartilage and synovial fluids of patients with rheumatoid arthritis Clin Rheumatol 16 2 1997 133 140
51. H. Matsuno, K. Yudoh, Y. Watanaba, F. Nakazawa, H. Aono, and T. Kimura Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membranes bound Fas ligand J Rheumatol 28 1 2001 22 28
52. H. Takaishi, T. Kimura, S. Dlai, Y. Okada, and J. D'Armiento Joint diseases and matrix metalloproteinases: a role for MMP-13 Curr Pharm Biotechnol 9 1 2008 47 54
53. S.W. Cox, B.M. Eley, M. Kiili, A. Asikainen, T. Tervahartiala, and T. Sorsa Collagen degradation by interleukine 1β-stimulated gingival fibroblasts is accompanied by release and activation of multiple matrix metalloproteinases and cysteine proteinases Oral Dis 12 2006 34 40
54. E. Bourguet, J. Sapi, H. Emonard, and W. Hornebeck Control of melanoma invasiveness by anticollagenolytic agents: a reappraisal of an old concept Anticancer Agents Med Chem 9 5 2009 576 579